The Hollings Cancer Center (HCC) is the focus of cancer care and research activities at MUSC. HCC opened its first 86,000 gross sq. ft. dedicated facility in 1993 at Jonathan Lucas and Calhoun Streets.
To accommodate the expanding clinical activities and provide additional space for the growth of basic and translational research, MUSC completed a seven-story tower adjacent to the former HCC building in 2006. As part of the expansion project, the first two floors of the original building were remodeled. This brings the total HCC facility to 202,139 gross square feet.
Patient Care Areas
- 46 exam and consult rooms
- A 39-chair day treatment and chemotherapy infusion suite
- Breast imaging suite
- Outpatient pharmacy
- Radiation oncology treatment suite with linear accelerator and TomoTherapy
- 24 new configurable lab modules with three benches each in addition to original labs
- Shared equipment rooms (cold rooms, warm room, molecular imaging core, drug discovery core, drug metabolism and clinical pharmacology core, etc.)
- Animal Facility with new Small Animal Imaging Suite
- Clinical Trials Office
Administrative and Educational Areas
- 58 administrative and faculty offices
- 6 conference rooms
- Large conference center
- Hollings Café
- Pearlstine Healing Garden
- Hope Chapel
- Patient Resource Center
- Integrative Cancer Care, our service offering therapeutic massage, nutritional counseling and supplements, mastectomy products and fittings, wigs, and hats
In addition to the Hollings Cancer Center facility, cancer clinicians and investigators utilize substantial facilities for interdisciplinary research, training and patient care across the campus and at the adjacent Ralph H. Johnson VA Medical Center.
>> More information on the Ralph H. Johnson VA Medical Center
The Cancer Genomics & BioEngineering Building
In 2009, MUSC broke ground for a 90,000-square-foot Cancer Genomics and Bioengineering Building adjoining the Drug Discovery Building. It will house a state-of-the-art small animal imaging facility as well as robust research programs in cancer prevention and control, cancer genetics, regenerative medicine and tissue engineering.
This 90,000-square-foot facility is an outgrowth of our long-standing and growing statewide program in Bioengineering and Regenerative Medicine. This facility will house engineering students and faculty from USC and Clemson, working and learning with our life and health science students and faculty. The building will also house new recruits for the HCC in areas of cancer genetics ans stem cell biology (30,000 s.f.) The facility will lay the groundwork for a systems--or integrative biology program at MUSC.
The Drug Discovery Building (DDB)
The 114,000-square-foot DDB will be comprised of state-of-the-art laboratory and biotech start-up space. The first floor will house the NMR Core, the Pharmacy Teaching laboratories and an auditorium. The second floor will include Structural Biology laboratories and space for biotech start-up companies.
Levels three and four will house 62,000 square feet of cancer research laboratories. This will include member labs for Developmental Cancer Therapeutics and the Drug Discovery/Screening Shared Resource, and Drug Metabolism and Clinical Pharmacology Shared Resource. Level five will be home to Advanced Cellular Technologies and Organ Failure Research laboratories. The DDB is scheduled to be completed in 2011.